Navigation Links
Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors

ay restore normal function to genes that are critical for differentiation and proliferation. The cytotoxic effects of azacitidine cause the death of rapidly dividing cells, including cancer cells that are no longer responsive to normal growth control mechanisms. Non-proliferating cells are relatively insensitive to Vidaza.

Important Safety Information

Vidaza is contraindicated in patients with a known hypersensitivity to azacitidine or mannitol and in patients with advanced malignant hepatic tumors. In clinical studies, the most commonly occurring adverse reactions were nausea (70.5%), anemia (69.5%), thrombocytopenia (65.5%), vomiting (54.1%), pyrexia (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia (32.3%) and ecchymosis (30.5%). Other adverse reactions included dizziness (18.6%), chest pain (16.4%), febrile neutropenia(16.4%), myalgia (15.9%), injection site reaction (13.6%), aggravated fatigue (12.7%) and malaise (10.9%). Because treatment with Vidaza is associated with neutropenia and thrombocytopenia, complete blood counts should be performed as needed to monitor response and toxicity, but at a minimum, prior to each dosing cycle. Because azacitidine is potentially hepatotoxic in patients with severe pre-existing hepatic impairment, caution is needed in patients with liver disease. In addition, azacitidine and its metabolites are substantially excreted by the kidneys and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, it may be useful to monitor renal function. Vidaza may cause fetal harm. While receiving treatment with Vidaza, women of childbearing potential should avoid becoming pregnant, and men should avoid fathering a child. In addition, women treated with Vidaza should not nurse.

About MDS

The highest prevalence of MDS is i
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/14/2009)... HEIGHTS, N.J., Dec. 14 Authentidate ... worldwide provider of secure Health Information Exchange ... Home Care of the Carolinas ("HCC"), a ... ("AMI"), a durable medical equipment supplier, have ... streamline and standardize processes for the completion ...
(Date:12/14/2009)... 14 Accuray Incorporated (Nasdaq: ARAY ... radiosurgery, announced today that the first CyberKnife® Robotic ... the University Hospital of Liege. ,, The ... one of the largest hospitals in Euregio, a ... "With a full range of cancer treatments, University ...
(Date:12/14/2009)... The U.S. Food and ... Extended Release Injectable Suspension for the treatment of ... LLY ) announced today. ZYPREXA RELPREVV, ... olanzapine for up to four weeks. ,, Different ... formulations of antipsychotics allow for stable concentrations of ...
Breaking Medicine Technology:Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8New stove dramatically improves lung health in Mexican women 58102 1New stove dramatically improves lung health in Mexican women 58102 2New stove dramatically improves lung health in Mexican women 58102 3Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 1Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 2Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference 58099 3New NIST nano ruler sets some very small marks 14219 1New NIST nano ruler sets some very small marks 14219 2
... Replacement Therapy Significantly,Improved Absorption of Fat and ... DAYTON, Ohio, April 04, 2007 /PRNewswire/ --,Eurand, ... from two phase III clinical trials on ... the treatment of,Exocrine Pancreatic Insufficiency (EPI). The ...
... WIRE)--Apr 4, 2007 - CytoGenix, Inc. (CYGX.OB),announced ... important,pilot study with a novel synDNA(TM) vaccine ... against the avian (H5N1),influenza virus. The study ... treated with the Company's synDNA(TM) vaccine,whereas all ...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5CytoGenix Announces Successful Testing of synDNA Vaccine for Avian,Influenza Virus 2
(Date:12/15/2009)... of Spa, Massage, and Medical tables announces its partnership with ... comfort system to ease pressure felt while laying face down ... ... Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., the premier ... the launch of the Utopian Massage Table with patent pending ...
(Date:12/15/2009)... entire San Diego Hospice and The Institute for Palliative ... December 14, 2009. Mr. Price has been known for ... his business, community and personal life. Mr. Price was ... responsibility of philanthropy and the role it plays in ... his countless philanthropic efforts. We extend our condolences to ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... 14 Pepsi Bottling Group, ArvinMeritor, Inc., ... are among the major employers that implemented Thomson ... their employees make better decisions about their benefits. ... personalized summary of their families, use of healthcare ... this personalized information, employees can determine which of ...
(Date:12/14/2009)... Dec. 14 Haemonetics Corporation (NYSE: ... filed a new legal action to stop Fenwal ... released red cell collection kits, using a modified ... chamber to circumvent Haemonetics, patent and the injunction ... of infringing products after December 1, 2010. ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 2Health News:Haemonetics Files a New Legal Action to Stop Fenwal Inc.'s Continued Patent Infringement 3
... SAN FRANCISCO, Calif., May 13 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... Vice President, Corporate Development and Finance, will,provide a corporate ... Healthcare Conference at 9:00 a.m. local time on Monday, ... in Monte Carlo, Monaco., Interested parties may access ...
... Claims Review from,Leading Insurance Companies and Social Security ... Data from the annual,Long-Term Disability Claims Review released ... the continued growth of serious,disabilities among the U.S. ... of U.S. workers with long-term disabilities has grown ...
... Sunkist Take a Stand Campaign Returns For Its Fifth Year ... Stands to Kids Raising Money For Charity, SHERMAN OAKS, ... back for a fifth year and bigger than ever. This ... promote youth philanthropy with the distribution of,20,000 free lemonade stands ...
... Storage Array to boost post production ... ... Electronics, Inc.,( http://www.jmr.com ), a premier supplier of Storage and Server ... PCIe RAID Storage System with PeSAN(TM) Technology,has been in use at ...
... May 13 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. ... of pharmaceutical, medicinal and diagnostic products in China,today ... at 5:00 p.m. Eastern,Time on May 15, 2008 ... Joining Mr. Yan-qing Liu, Chairman, CEO and ...
... had no such benefit if baby was bottle-fed, researchers ... who breast feed for more than one year reduce ... to a new Swedish study. , The researchers also ... no protection against the disease. , Taking oral contraceptives ...
Other Medicine News:Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 2Health News:New Data Shows Continued Growth of Long-Term Disability Claims and Decline in Social Security Disability Insurance Applications Approval Rate 3Health News:Kids Squeeze 'Aid' Out of Lemons as Take a Stand(R) Program Launches Nationwide 2Health News:Kids Squeeze 'Aid' Out of Lemons as Take a Stand(R) Program Launches Nationwide 3Health News:JMR Electronics BlueStor(TM) Storage Array Empowers HoneyShed's Post Production Process 2Health News:JMR Electronics BlueStor(TM) Storage Array Empowers HoneyShed's Post Production Process 3Health News:JMR Electronics BlueStor(TM) Storage Array Empowers HoneyShed's Post Production Process 4Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Breast-feeding Might Shield Women From Rheumatoid Arthritis 2
... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
... (HCH) capture the patient`s exhaled heat and ... gas. Small and compact, they are specially ... Depending on the tidal volume requirements, select ... ,The adult HCH is ideal for patient ...
... These hygroscopic condenser humidifiers (HCH) capture the ... them in the inspired gas. Small and ... bacteriostatic and hygroscopic benefits. Depending on the ... or small-volume model., ,The adult HCH ...
Medicine Products: